A randomized Phase III study of doxorubicin versus cisplatin/interferon alpha-2b/Docorubicin/Fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma

Research output: Contribution to journalArticle


  • W Yeo
  • TS Mok
  • B Zee
  • TWT Leung
  • PBS Lai
  • WY Lau
  • J Koh
  • FKF Mo
  • SCH Yu
  • AT Chan
  • P Hui
  • B Ma
  • KC Lam
  • WM Ho
  • HT Wong
  • A Tang

Colleges, School and Institutes


Original languageEnglish
Pages (from-to)1532-1538
Number of pages7
JournalJournal of the National Cancer Institute
Publication statusPublished - 19 Oct 2005